Hypersensitivity to salphasalazine: Value of desensitization;Hypersensibilité à l'acide 5-aminosalicylique. Intérêt de la désensibilisation par voie orale

Archives de Pediatrie

Volumn 4, Issue 2, 1997, Pages 144-146

  Lachaux, A ^a   Le Gall, C ^a   Loras Duclaux, I ^a   Aboufadel, A ^a   Hermier, M ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Adolescent medicine; Aminosalicylic acids; Angioneurotic edema; Crohn's disease; Desensitization, immunologie; Hypersensitivity

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; GASTROINTESTINAL AGENT; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; PREDNISONE;

ARTICLE; CASE REPORT; CHILD; CROHN DISEASE; DESENSITIZATION; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; ANGIONEUROTIC EDEMA; EOSINOPHILIA; SCHOOL CHILD; URTICARIA;

ADMINISTRATION, ORAL; AMINOSALICYLIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CROHN DISEASE; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MESALAMINE; SULFASALAZINE;

EID: 0031039418     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0929-693x(97)86158-1     Document Type: Article

References (10)

1. Seidman E. Crohn's disease. In: Roy CC, Silverman A, Alagille D. eds. Pediatric clinical gastroenterology. Fourth edition. Saint Louis: Mosby, 1995:462-93
2. Delboy H. Les effets indésirables de la salicyl-azo-sulfapyridine. Sem Hôp Paris 1992;68:180-7
3. Modigliani R, Rambaud JC. Les nouveaux dérivés de la salazosulfapyridine. Un progrès dans le traitement des maladies inflammatoires chroniques de l'intestin. Gastroentérol Clin Biol 1987;11:325-32
4. Peppercorn MA, Update on aminosalicylates: a promise fulfilled. Gastroenteroiogy 1988;95:1677-83
5. Hautekeete ML, Bourgeois N, Potvin P et al. Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine. Gastroenteralogy 1992;103:1925-7
6. Turunen U, Elomaa I, Anttila VJ, Seppälä K. Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides. Scand J Gastroenterol 1987;22:798-802
7. Hayllar J, Bjarnason I. Sulphasalazine in ulcerative colitis: in memoriam? Gut 1991;32:462-3
8. S Kristensen KS, Hoegholm A, Bohr L, Friis S. Fatal myocarditis associated with mesalazine [Letter]. Lancet 1990;335:605
9. Fardy JM, Lloyd DA, Reynolds RPE. Adverse effects with 1988;10:635-7
10. Holdsworth CD. Sulphasalazine desensitisation. Br Med J 1981;282:110